Hormone replacement therapy and accuracy of mammographic screening

Lancet

Volumn 355, Issue 9200, 2000, Pages 270-274

  Kavanagh, Anne M ^a   Mitchell, Heather ^b   Giles, Graham G ^a  

^a CANCER EPIDEMIOLOGY CENTRE   (Australia)

^b Victorian BreastScreen Registry   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; BREAST CANCER; DIAGNOSTIC ACCURACY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MODEL; PRIORITY JOURNAL; SCREENING;

EID: 0034700867     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)07319-5     Document Type: Article

References (40)

1. Hurley S.F., Kaldor J.M. The benefits and risks of mammographic screening for breast cancer. Epidemiol Rev. 14:1992;101-130.
2. Kerlikowske K., Grady D., Barclay J., Sickles E.A., Ernster V. Effect of age, breast density and family history on the sensitivity of first screening mammography. JAMA. 276:1996;33-38.
3. Kerlikowske K., Grady D., Barclay J., Sickles E.A., Eaton A., Ernster V. Positive predictive value of screening mammography by age and family history of breast cancer. JAMA. 270:1993;2444-2450.
4. Peer P.G.M., Verbeek A.L.M., Straatman H., Hendriks J.H.C.L., Holland R. Age-specific sensitivities of mammographic screening for breast cancer. Breast Cancer Res Treat. 38:1996;153-160.
5. Schouten L.J., de Rijke J.M., Schlangen J.T., Veerbeek A.L. Hormone replacement therapy and high incidence of breast cancer between mammographic screens. Lancet. 349:1997;1104.
6. Ma L., Fishell E., Wright B., Hanna W., Allan S., Boyd N.F. Case-control study of factors associated with failure to detect breast cancer by mammography. J Natl Cancer Inst. 84:1992;781-785.
7. van Gils C.H., Otten J.D.M., Verbeek A.L.M., Hendriks J.H.C.L., Holland R. Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, the Netherlands. J Epidemiol Community Health. 52:1998;267-271.
8. Laya M.B., Larson E.B., Taplin S.H., White E. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst. 88:1996;643-649.
9. Litherland J.C., Evans A.J., Wilson A.R.M. The effect of hormone replacement therapy on recall rate in the National Health Service Breast Screening Programme. Clin Radiol. 52:1997;276-279.
10. Thurfjell E.L., Holmberg L.H., Persson I.R. Screening mammography: sensitivity and specificity in relation to hormone replacement therapy. Radiology. 203:1997;339-341.
11. Séradour B., Estève J., Heid P., Jacquemier J. Hormone replacement therapy and screening mammography: analysis of the results of the du Rhône programme. J Med Screen. 6:1999;99-102.
12. Rosenberg R.D., Hunt W.C., Williamson M.R.et al. Effects of age, breast density, ethnicity and estrogen replacement therapy on the sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology. 209:1998;511-518.
13. Litherland J.C., Stallard S., Hole D., Cordiner C. The effect of hormone replacement therapy on the sensitivity of screening mammograms. Clin Radiol. 54:1999;285-288.
14. Cohen M.E.L. Effect of hormone replacement therapy on cancer detection by mammography. Lancet. 349:1997;1624.
15. MacLennan A.H., Taylor A.W., Wilson D.H. Changes in the use of hormone replacement therapy in South Australia. Med J Aust. 162:1995;420-422.
16. Beral V., Banks E., Reeves G., Wallis M. Hormone replacement therapy and high incidence of breast cancer between mammographic screens. Lancet. 349:1997;1103-1104.
17. Threlfall A.G., Woodman C.B.J., Prior P. Breast screening programme: should the interval between tests depend on age? Lancet. 349:1997;472.
18. Tabar L., Faberberg G., Day N.E., Holmberg L. What is the optimum interval between mammographic screening examinations? An analysis on the latest results of the Swedish Two-County Breast Cancer Screening Trial. Br J Cancer. 55:1987;547-551.
19. Australian Bureau of Statistics. Australian Demographic Statistics. Canberra: Australian Bureau of Statistics, 1999.
20. Kavanagh A.M., Mitchell H., Farrugia H., Giles G.G. Monitoring interval cancers in an Australian mammographic screening program. J Med Screen. 6:1999;139-143.
21. McNicholas M.M.J., Heneghan J.P., Milner M.H., Tunney T., Hourihane J.B., MacErlaine D.P. Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study. Am J Roentgenol. 163:1994;311-315.
22. Bergkvist L., Tabar L., Adami H.O., Persson I., Bergstrom R. Mammographic parenchymal patterns in women receiving noncontraceptive estrogen treatment. Am J Epidemiol. 130:1989;503-510.
23. Leung W., Goldberg F., Zee B., Sterns E. Mammographic density in women on postmenopausal hormone replacement therapy. Surgery. 122:1997;669-674.
24. Rand T., Heytmanek G., Seifert M.et al. Mammography in women undergoing hormone replacement therapy. Possible effects revealed at routine examination. Acta Radiol. 38:1997;228-231.
25. Wald N.J., Murphy P., Major P., Parkes C., Townsend J., Frost C. UKCCR multicentre randomised controlled trial of one and two view mammography and breast cancer screening. BMJ. 311:1995;1189-1193.
26. Marugg R.C., van der Mooren M.J., Hendriks J.H., Rolland R., Ruijs S. Mammographic changes in postmenopausal women on hormone replacement therapy. Eur Radiol. 7:1997;749-755.
27. Stomper P.C., Van Voorhis B.J., Ravnikar V.A., Meyer J.E. Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology. 174:1990;487-490.
28. Laya M.B., Callagher J.C., Schreiman J.S., Larson E.B., Watson P., Weinstein L. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology. 196:1995;433-437.
29. Persson I., Thurfjell E., Holmberg L. Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. J Clin Oncol. 15:1997;3201-3207.
30. Berkowitz J.E., Gatewood O.M.B., Goldblum L.E., Gayler B.W. Hormonal replacement therapy: mammographic manifestations. Radiology. 174:1990;199-201.
31. Lundström E., Wilczek B., von Palffy Z., Söderqvist G., von Schoultz B. Mammographic breast density during hormone replacement therapy: differences according to treatment. Am J Obstet Gynecol. 181:1999;348-352.
32. Shelley J.M., Smith A.M., Dudley E., Dennerstein L. Use of hormone replacement therapy by Melbourne women. Aust N Z J Public Health. 19:1995;387-392.
33. Salmon R.J., Remvikos Y., Ansquer Y., Asselain B. HRT and breast cancer. Lancet. 346:1995;1702-1703.
34. Harding C., Knox W.F., Faragher E.B., Baildam A., Bundred N.J. Hormone replacement therapy and tumour grade in breast cancer: prospective study in screening unit. BMJ. 312:1996;1646-1647.
35. Magnusson C., Holmberg L., Nordén T., Lindgren A., Persson I. Prognostic characteristics in breast cancers after hormone replacement therapy. Breast Cancer Res Treat. 38:1996;325-334.
36. Holli K., Isola J., Cuzick J. Hormone replacement therapy and the biological aggressiveness of breast cancer. Lancet. 350:1997;1704-1705.
37. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet. 350:1997;1047-1059.
38. Roubidoux M., Wilson T., Orange R., Fitzgerald J., Helvie M., Packer S. Breast cancer in women who undergo screening mammography: relationship of hormone replacement therapy to stage and detection method. Radiology. 208:1998;725-728.
39. Brisson J., Morrison A.S., Khalid N. Mammographic parenchymal features and breast cancer detection demonstration project. J Natl Cancer Inst. 80:1988;1534-1540.
40. Harvey J.A., Pinkerton J.V., Herman C.R. Short-term cessation of hormone replacement therapy and improvement of mammographic specificity. J Natl Cancer Inst. 89:1997;1623-1625.